1. Home
  2. BBVA vs BMY Comparison

BBVA vs BMY Comparison

Compare BBVA & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBVA

Banco Bilbao Vizcaya Argentaria S.A.

HOLD

Current Price

$29.21

Market Cap

134.0B

Sector

Finance

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$67.28

Market Cap

113.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBVA
BMY
Founded
1857
1887
Country
Spain
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.0B
113.5B
IPO Year
2002
2006

Fundamental Metrics

Financial Performance
Metric
BBVA
BMY
Price
$29.21
$67.28
Analyst Decision
Buy
Buy
Analyst Count
2
15
Target Price
N/A
$61.73
AVG Volume (30 Days)
1.8M
11.9M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
4.08%
4.38%
EPS Growth
N/A
178.46
EPS
N/A
2.93
Revenue
N/A
$48,194,000,000.00
Revenue This Year
$29.69
N/A
Revenue Next Year
$5.39
N/A
P/E Ratio
$11.24
$22.87
Revenue Growth
N/A
N/A
52 Week Low
$17.77
$42.52
52 Week High
$29.13
$68.64

Technical Indicators

Market Signals
Indicator
BBVA
BMY
Relative Strength Index (RSI) 71.55 63.48
Support Level $20.34 $56.46
Resistance Level N/A $68.10
Average True Range (ATR) 0.30 1.51
MACD -0.04 0.04
Stochastic Oscillator 91.49 72.52

Price Performance

Historical Comparison
BBVA
BMY

About BBVA Banco Bilbao Vizcaya Argentaria S.A.

Despite its Spanish origins, Banco Bilbao Vizcaya Argentaria generates only around one-fourth of its profits in Spain. We expect that on a normalized basis, BBVA's market-leading Mexican bank should contribute half of its earnings, while its Turkish operation should account for another 15%. The balance of BBVA's earnings comes from smaller operations in South America. BBVA is overwhelmingly a retail and commercial bank, with corporate and investment banking forming a minor part of the overall business. BBVA also offers insurance and investment products through its banking networks.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: